Harsimran Saini
Clinical Cardiac Electrophysiology · Richmond, VANPI 1619105061
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (53.7%), food and beverage and education — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Medtronic at 45.3% of the total. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in VA, where the typical reported total is $19,771.
Across 201 payments — averaging $82.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$8K
- Boston Scientific$6K
- Abbott$956
- Biosense Webster, Inc.$397
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$271
- Cardiva Medical, Inc.$221
- plus $1K from 24 others
Across 6 payments — averaging $4276.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$26K
What the payments were for
- Travel & lodging$8,89254%
- Food & beverage$7,59146%
- Education$800%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 46 | $7,503 |
| Boston Scientific | 50 | $5,841 |
| Abbott | 24 | $956 |
| Biosense Webster, Inc. | 4 | $397 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 15 | $271 |
| Cardiva Medical, Inc. | 4 | $221 |
| Boehringer Ingelheim | 9 | $192 |
| Impulse Dynamics (USA) Inc. | 1 | $147 |
| Pfizer | 8 | $139 |
| CSL Behring | 2 | $137 |
| Penumbra, Inc. | 6 | $133 |
| Alnylam Pharmaceuticals Inc. | 7 | $116 |
| Atricure, Inc. | 2 | $68 |
| Cordis US CORP. | 2 | $63 |
| Amgen | 3 | $49 |
| Stryker | 2 | $43 |
| Bayer | 2 | $32 |
| Irhythm Technologies, Inc. | 1 | $26 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $26 |
| BD | 1 | $25 |
| E.r. Squibb & Sons, L.L.C. | 2 | $25 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $24 |
| Merck | 1 | $19 |
| Abiomed | 1 | $18 |
| Novo Nordisk | 1 | $18 |
| Novartis | 1 | $17 |
| Bridgebio Pharma, Inc. | 1 | $17 |
| Terumo Medical Corporation | 1 | $15 |
| Kestra Medical Technology Services, Inc. | 1 | $15 |
| Bardy Diagnostics, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Farapulse$2,621
- Arctic Front$2,042
- PulseSelect$1,922
- Performa$1,282
- Watchman$1,262
- Micra$1,050
- OPTIMIZER$293
- Perclose ProStyle$288
- Carto 3$272
- WATCHMAN Access System$258
- GENERAL - THERAPIES$242
- AFFERA MAPPING SYSTEM$163
- INGEVITY$146
- Ensite Cardiac Mapping System$121
- SureScan$120
- Kcentra$117
- WATCHMAN FLX$113
- CARDIVA VASCADE MVP XL VVCS 10-12F$112
- TACTICATH ABLATION CATHETER, SENSOR ENABLED$105
- AVEIR$102
How this compares
$16,563 in reported general payments places this provider in the 40th percentile of 90 clinical cardiac electrophysiology providers in Virginia.
See all clinical cardiac electrophysiology providers in Virginia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 815 | $894,763 |
| XareltoRivaroxaban | 299 | $361,793 |
| EntrestoSacubitril/Valsartan | 90 | $90,784 |
| JardianceEmpagliflozin | 14 | $21,259 |
| FarxigaDapagliflozin Propanediol | 11 | $11,654 |
| Flecainide Acetate | 202 | $7,170 |
| Metoprolol Succinate | 362 | $5,117 |
| SotalolSotalol Hcl | 170 | $3,836 |
| Amiodarone Hcl | 145 | $3,731 |
| Dofetilide | 21 | $3,582 |
| Valsartan | 22 | $2,414 |
| Propafenone Hcl | 55 | $2,256 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 54 | $1,677 |
| Diltiazem 24hr ErDiltiazem Hcl | 45 | $1,593 |
| ClopidogrelClopidogrel Bisulfate | 151 | $1,500 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $139 | $894,763815 claims |
| NovartisEntresto | $17 | $90,78490 claims |
| Boehringer IngelheimJardiance | $192 | $21,25914 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 90 clinical cardiac electrophysiology providers in Virginia.
Other clinical cardiac electrophysiology in Richmond
- Kenneth EllenbogenRichmond$360K
- Ajay PillaiRichmond$129K
- Charles JoynerRichmond$85K
- Binaya BasyalRichmond$79K
- Jayanthi KoneruRichmond$62K
- Kyaw Min KhantRichmond$51K
- Jacob BlackwellRichmond$49K
- Pranav MankadRichmond$30K
- Vybhav JettyRichmond$20K
- David GilliganRichmond$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.